Company: PTHS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001753926-25-001764
Chunk: 55

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 55
---
 September 30, 2024  
    September 30, 2025  
    September 30, 2024 

    Stock options 
    $2,001  
    $395  
    $2,747  
    $1,054 

    Restricted stock units 
     811  
     42  
     915  
     56 

    Total 
    $2,812  
    $437  
    $3,662  
    $1,110 

The
following provides detail regarding future stock-based compensation as of September 30, 2025:

    As of September 30, 2025

     Unamortized Expense  
    Remaining Life

    Stock options 
    $12,801  
    2.68 years

    Restricted stock units 
    $5,800  
    2.64 years

    34

Stock
Options

The
activity related to stock options during the nine months ended September 30, 2025 consisted of the following:

    Stock Options 
    Number
of  Shares   
    Weighted  Average  Exercise  Price   
    Weighted  Average  Remaining  Life  

    Outstanding December 31, 2024 
     87,049  
    $58.50  

    Granted 
     1,458,775  
     13.54  

    Expired 
     (9,923) 
     65.58  

    Exercised 
     (6,500) 
     13.00  

    Outstanding September 30, 2025 
     1,529,401  
    $15.76  
     9.69 years 

    Exercisable September 30, 2025 
     133,429  
    $38.95  
     8.51 years 

The
activity related to stock options during the nine months ended September 30, 2024 consisted of the following:

    Stock Options 
    Number
of  Shares   
    Weighted  Average  Exercise  Price   
    Weighted  Average  Remaining  Life  

    Outstanding December 31, 2023 
     19,756  
    $226.80  

    Granted 
     63,400  
    $13.00  

    Expired